ANNUAL REPORT FY22 21 Liquidity and capital resources Nyrada ended the financial year with cash of $10,816,039 and anticipates to receive an Research and Development tax incentive refund for the FY2022 of $1,048,333 following 30 June 2022, further boosting capital resources. Matters subsequent to the end of the financial year On 1 August 2022 the Company announced the appointment of Dr. Gisela Mautner as a Non-Executive Director to its Board and retirement of Peter Marks. No other matters or circumstances have arisen since 30 June 2022 that has significantly affected, or may significantly affect the Consolidated Entity's operations, the results of those operations, or the Consolidated Entity's state of affairs in future financial years. Future developments, prospects, and business strategies Disclosure of information regarding likely developments in the operations of the Company in future financial years and the expected results of those operations is likely to result in unreasonable prejudice to the Company. Information on future developments, prospects, and business strategies have only been referred to in the Chairman’s Letter and CEO Report. For further information on the Company’s business strategies andmaterial risks, refer also to the Prospectus which is available on the Company website or ASX Announcements. Environmental regulation The Consolidated Entity is not subject to any significant environmental regulation under Australian Commonwealth or State law. Directors’ shareholdings In this section, reference is made to Share ownership. The instruments registered for trade on the Australian Securities Exchange are CHESS Depositary Interests (CDIs). One CDI is equivalent to one Share, being Class A Common Stock. The following table sets out each director’s relevant interest in shares, debentures, and rights or options in shares or Directors of the Company or a related body corporate as at the date of this report: Share Number Options Number Performance Shares John Moore 358,423 3,600,000 - Peter Marks 250,000 2,600,000 - Rüdiger Weseloh 100,000 1,800,000 - Marcus Frampton 245,075 1,800,000 - Christopher Cox 1,425,000 1,800,000 - Ian Dixon 10,114,033 1,800,000 5,999,400 Gisela Mautner - - - Options Granted There were no options granted during the financial year.